Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto que contiene benzocaína y mepiramina en forma farmacéutica para administración cutánea como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | Topical form antihistamine (product) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con mepiramina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con benzocaína | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Sedating antihistamine (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Skin agent (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Mepyramine | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Benzocaine (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | pyrilamine maleate+benzocaine (product) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Mepyramine maleate | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Mepyramine (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene ingrediente activo (atributo) | Ethylenediamine derivative antihistamine | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto con benzocaína y mepiramina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | Product manufactured as topical dosage form (product) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | Product containing mepyramine in topical dosage form (medicinal product form) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | es un[a] | producto que contiene benzocaína en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has manufactured dose form | Cutaneous spray | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Benzocaine (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator value | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene base de sustancia de la potencia | Benzocaine (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength denominator value | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Count of base of active ingredient | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | tiene base de sustancia de la potencia | Mepyramine maleate | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator value (attribute) | 20 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Mepyramine maleate | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) | Has concentration strength numerator value (attribute) | 20 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets